Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

International Journal of Stroke

Volumn 16, Issue 2, 2021, Pages 222-228

  Chen, Xiaoying ^a,b   Li, Jingwei ^a,c,d   Anderson, Craig S ^a,e,f   Lindley, Richard I ^b   Hackett, Maree L ^a,b,g   Robinson, Thompson ^h,i   Lavados, Pablo M ^j,k   Wang, Xia ^a   Arima, Hisatomi ^a,l   Chalmers, John ^a   Delcourt, Candice ^a,b,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b University of Sydney   (Australia)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

ⁱ NIHR Leicester Biomedical Research Centre Cardiovascular Diseases   (United Kingdom)

^j UNIVERSITY OF CHILE   (Chile)

^k UNIVERSIDAD DEL DESARROLLO   (Chile)

^l FUKUOKA UNIVERSITY   (Japan)

more..

Author keywords

clinical trial; health outcome; ischemic stroke; modified Rankin scale; Simplified modified Rankin scale questionnaire

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISABILITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS QUESTIONNAIRE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; TREATMENT OUTCOME; TREATMENT PLANNING; VALIDATION STUDY; REPRODUCIBILITY;

BRAIN ISCHEMIA; HUMANS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 85078352194     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1177/1747493019897858     Document Type: Article

References (23)

1. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; 20: 828.
2. Saver JL, Filip B, Hamilton S, et al. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke 2010; 41: 992–995.
3. Dennis M, Mead G, Doubal F, Graham C. Determining the modified Rankin Score after stroke by postal and telephone questionnaires. Stroke 2012; 43: 851–853.
4. Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke 2002; 33: 2243–2246.
5. Bruno A, Shah N, Lin C, et al. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke 2010; 41: 1048–1050.
6. Bruno A, Shah N, Akinwuntan AE, Close B, Switzer JA. Stroke size correlates with functional outcome on the simplified modified Rankin Scale questionnaire. J Stroke Cerebrovasc Dis 2013; 22: 781–783.
7. Bruno A, Akinwuntan AE, Lin C, et al. Simplified modified Rankin Scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke 2011; 42: 2276–2279.
8. Bruno A, Close B, Switzer JA, et al. Simplified modified Rankin Scale questionnaire correlates with stroke severity. Stroke 2013; 27: 724–727.
9. Yuan JL, Bruno A, Li T, et al. Replication and extension of the simplified modified Rankin Scale in 150 Chinese stroke patients. Eur Neurol 2012; 67: 206–210.
10. Anderson CS, Robinson T, Lindley RI, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 2016; 374: 2313–2323.
11. Huang Y, Sharma VK, Robinson T, et al. Rationale, design, and progress of the Enhanced Control of Hypertension ANd thrombolysis strokE stuDy (ENCHANTED) trial: an international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Int J Stroke 2015; 10: 778–788.
12. Dolan P, Gudex C, Kind P and Williams A. A social tariff for EuroQol: results from a UK general population survey. Centre for Health Economics, The University of York. Discussion Paper 138, 1995. https://www.york.ac.uk/che/pdf/DP138.pdf (accessed 20 Oct 2019)
13. Kind P, Hardman G and Macran S. UK population norms for EQ-5D. Centre for Health Economics, The University of York. Discussion Paper 172, 1999. https://www.york.ac.uk/che/pdf/DP172.pdf (accessed 20 Oct 2019)
14. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213–220.
15. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: 1491–1494.
16. Wahlgren AN, Ahmed GN, Eriksson RN, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Stroke 2008; 39: 3316–3322.
17. Hankey GJ, Spiesser J, Hakimi Z, et al. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 2007; 68: 1583–1587.
18. Katzan IL, Thompson NR, Lapin B, et al. Added value of patient-reported outcome measures in stroke clinical practice. J Am Heart Assoc 2017; 6: e005356.
19. Rangaraju S, Haussen D, Nogueira RG, Nahab F, Frankel M. Comparison of 3-month stroke disability and quality of life across modified Rankin scale categories. Interv Neurol 2017; 6: 36–41.
20. Mihindu E, Mohammed A, Smith T, Brinster C, Sternbergh WC 3rd, Bazan HA. Patients with moderate to severe strokes (NIHSS score > 10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes. J Vasc Surg 2019; 69: 1471–1481.
21. De Raedt S, Brouns R, De Smedt A, et al. The sNIHSS-4 predicts outcome in right and left anterior circulation strokes. Clin Neurol Neurosurg 2013; 115: 729–731.
22. Costalat V, Lobotesis K, Machi P, et al. Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke (RECOST study): 50 patients prospective study. Eur J Radiol 2012; 81: 4075–4082.
23. Dennis M, Mead G, Forbes J, et al. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 2019; 393: 265–274.